These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 28864222
21. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma. Winer AG, Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G, Coleman JA. Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270 [Abstract] [Full Text] [Related]
22. Management of upper urinary tract urothelial carcinoma. Sun M, Abdo A, Abdollah F, Schmitges J, Thuret R, Jeldres C, Shariat SF, Perrotte P, Karakiewicz PI. Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761 [Abstract] [Full Text] [Related]
23. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma. Meng X, Chao B, Vijay V, Silver H, Margolin EJ, Balar A, Taneja SS, Shah O, Bjurlin MA, Anderson CB, Huang WC. Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207 [Abstract] [Full Text] [Related]
24. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy. Shibing Y, Turun S, Qiang W, Junhao L, Haichao Y, Shengqiang Q, Ping H, Dehong C. Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374 [Abstract] [Full Text] [Related]
25. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration. Necchi A, Lo Vullo S, Mariani L, Moschini M, Hendricksen K, Rink M, Sosnowski R, Dobruch J, Raman JD, Wood CG, Margulis V, Roupret M, Briganti A, Montorsi F, Xylinas E, Shariat SF, European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Cancer Group and the Upper Tract Urothelial Carcinoma Collaboration group. BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605 [Abstract] [Full Text] [Related]
26. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract. Kang M, Jeong CW, Kwak C, Kim HH, Ku JH. Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011 [Abstract] [Full Text] [Related]
27. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study. Kang HW, Seo SP, Kim WT, Kim YJ, Yun SJ, Lee SC, Choi YD, Ha YS, Kim TH, Kwon TG, Byun SS, Jeh SU, Kim WJ. J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247 [Abstract] [Full Text] [Related]
28. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A. Inokuchi J, Kuroiwa K, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yamaguchi A, Matsuyama H, Ichikawa T, Asano T, Mizusawa J, Eba J, Naito S. World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102 [Abstract] [Full Text] [Related]
29. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma. Milojevic B, Dzamic Z, Kajmakovic B, Durutovic O, Bumbasirevic U, Sipetic Grujicic S. Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995 [Abstract] [Full Text] [Related]
30. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V. Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969 [Abstract] [Full Text] [Related]
31. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat SF, Fisch M, Fritsche HM, Gakis G. Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908 [Abstract] [Full Text] [Related]
33. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation. Zhang L, Xiong G, Fang D, Li X, Liu J, Ci W, Zhao W, Singla N, He Z, Zhou L. J Exp Clin Cancer Res; 2015 Jan 22; 34(1):5. PubMed ID: 25613404 [Abstract] [Full Text] [Related]
34. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, Guillotreau J, Guy L, Karsenty G, De La Taille A, Colin P, French Collaborative National Database on UTUC. BJU Int; 2013 Jun 22; 111(8):1199-207. PubMed ID: 23650914 [Abstract] [Full Text] [Related]
35. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M. Eur J Cancer; 2014 Oct 22; 50(15):2583-91. PubMed ID: 25088206 [Abstract] [Full Text] [Related]
36. Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National University Hospital experience. Kim HS, Lee JS, Jeong CW, Kwak C, Kim HH, Ku JH. Int Braz J Urol; 2015 Oct 22; 41(6):1067-79. PubMed ID: 26742963 [Abstract] [Full Text] [Related]
37. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA. Urol Oncol; 2014 Jan 22; 32(1):47.e9-14. PubMed ID: 24140248 [Abstract] [Full Text] [Related]
38. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Kim JK, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH. Urol Oncol; 2017 Jul 22; 35(7):458.e9-458.e15. PubMed ID: 28347659 [Abstract] [Full Text] [Related]
39. [OUTCOMES AFTER SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA]. Moritake J, Miki J, Tsuzuki S, Hata K, Shimomura T, Kimura T, Furuta A, Furuta N, Egawa S. Nihon Hinyokika Gakkai Zasshi; 2016 Jul 22; 107(2):79-86. PubMed ID: 28442674 [Abstract] [Full Text] [Related]
40. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. Tanaka N, Kikuchi E, Shirotake S, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Ito Y, Kosaka T, Kodaira K, Oyama M, Miyajima A, Momma T, Nakagawa K, Ueno M, Oya M. Eur Urol; 2014 Jan 22; 65(1):227-34. PubMed ID: 23219372 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]